As of 2024-07-27, the Relative Valuation of Marinus Pharmaceuticals Inc (MRNS) is (17.86) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.43 USD, the upside of Marinus Pharmaceuticals Inc based on Relative Valuation is -1348.9%.
The range of the Relative Valuation is (0.26) - (26.99) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.1x - 10.2x | 5.1x |
| Forward P/E multiples | 0.0x - 16.7x | 8.4x |
| Fair Price | (0.26) - (26.99) | (17.86) |
| Upside | -118.5% - -1987.3% | -1348.9% |
| Date | P/E |
| 2024-07-26 | -0.54 |
| 2024-07-25 | -0.53 |
| 2024-07-24 | -0.53 |
| 2024-07-23 | -0.56 |
| 2024-07-22 | -0.57 |
| 2024-07-19 | -0.54 |
| 2024-07-18 | -0.53 |
| 2024-07-17 | -0.53 |
| 2024-07-16 | -0.56 |
| 2024-07-15 | -0.53 |
| 2024-07-12 | -0.52 |
| 2024-07-11 | -0.50 |
| 2024-07-10 | -0.46 |
| 2024-07-09 | -0.47 |
| 2024-07-08 | -0.45 |
| 2024-07-05 | -0.45 |
| 2024-07-03 | -0.46 |
| 2024-07-02 | -0.45 |
| 2024-07-01 | -0.48 |
| 2024-06-28 | -0.44 |
| 2024-06-27 | -0.46 |
| 2024-06-26 | -0.48 |
| 2024-06-25 | -0.51 |
| 2024-06-24 | -0.52 |
| 2024-06-21 | -0.50 |
| 2024-06-20 | -0.51 |
| 2024-06-18 | -0.53 |
| 2024-06-17 | -0.55 |
| 2024-06-14 | -0.55 |
| 2024-06-13 | -0.55 |
| 2024-06-12 | -0.56 |
| 2024-06-11 | -0.59 |
| 2024-06-10 | -0.58 |
| 2024-06-07 | -0.57 |
| 2024-06-06 | -0.57 |
| 2024-06-05 | -0.58 |
| 2024-06-04 | -0.54 |
| 2024-06-03 | -0.56 |
| 2024-05-31 | -0.54 |
| 2024-05-30 | -0.55 |
| 2024-05-29 | -0.58 |
| 2024-05-28 | -0.57 |
| 2024-05-24 | -0.52 |
| 2024-05-23 | -0.49 |
| 2024-05-22 | -0.49 |
| 2024-05-21 | -0.50 |
| 2024-05-20 | -0.51 |
| 2024-05-17 | -0.50 |
| 2024-05-16 | -0.49 |
| 2024-05-15 | -0.50 |